M&A Corner
Sanofi Mulls Mirati Buy as KRAS Battle Heats Up: Bloomberg10 Oct 2023
Sanofi is reportedly considering the acquisition of cancer drugmaker Mirati Therapeutics, although discussions are ongoing, and no final decision has... Continue Reading
|
Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Bio10 Oct 2023
Talaris Therapeutics has declared a special cash dividend of approximately $1.5118 per share of Talaris common stock in connection with... Continue Reading
|
Netsmart Acquires Netalytics to Advance SUD Solutions10 Oct 2023
Netsmart, a healthcare technology company, has acquired Netalytics, a South Carolina-based software firm specializing in addiction treatment solutions. The acquisition... Continue Reading
|
Kyowa Kirin Buys Orchard for Potential $478M as FDA Decision Looms10 Oct 2023
Japanese pharmaceutical company Kyowa Kirin is set to acquire Orchard Therapeutics for around $478 million, subject to meeting certain conditions.... Continue Reading
|
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline10 Oct 2023
AbbVie has acquired Mitokinin, a biotech firm working on a potentially groundbreaking treatment for Parkinson’s Disease (PD). Mitokinin’s lead compound... Continue Reading
|
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate10 Oct 2023
Oragenics is set to acquire Odyssey Health’s proprietary neurological drug therapies and technologies. The assets include drug candidates for treating... Continue Reading
|
Abcam Files and Mails Scheme Circular Seeking Approval of Acquisition of Abcam by Danaher for $24.00 per Share10 Oct 2023
Danaher Corporation is set to acquire Abcam for $24.00 per share in cash, resulting in a pro-forma equity value of... Continue Reading
|
Precision Neuroscience Acquires U.S. Manufacturing Facility and Receives FDA Breakthrough Device Designation10 Oct 2023
Standard BioTools and SomaLogic have agreed to merge in an all-stock deal, creating a company with a pro-forma equity value... Continue Reading
|
Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools10 Oct 2023
Standard BioTools and SomaLogic have agreed to merge in an all-stock deal, creating a company with a pro-forma equity value... Continue Reading
|
Ounce Raises $5.2M to Bridge the Gap Between Housing and Health10 Oct 2023
Health and housing company Ounce has raised $5.2 million in a seed funding round co-led by Meridian Street Capital and... Continue Reading
|